---
figid: PMC7865811__ijms-22-01316-g003
figtitle: NFKB pathway by NLRX1
organisms:
- Human immunodeficiency virus 1
- Severe acute respiratory syndrome coronavirus 2
- Influenza A virus
- Human immunodeficiency virus
- Human papillomavirus type 16
- Orthomyxoviridae
- H1N1 subtype
- Vesicular stomatitis virus
- Vaccinia virus
- DNA viruses
- Encephalomyocarditis virus
- Enterovirus
- Simian immunodeficiency virus
- Escherichia coli
- Helicobacter pylori
- Listeria monocytogenes
- Shigella flexneri
- Fusobacterium nucleatum
- Chlamydia trachomatis
- Citrobacter rodentium
- Streptococcus sp. group A
- Aspergillus fumigatus
- Cryptococcus neoformans
- Histoplasma capsulatum
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Macaca mulatta
- prion
- NA
- NA
- NA
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Macaca mulatta
- Danio rerio
pmcid: PMC7865811
filename: ijms-22-01316-g003.jpg
figlink: pmc/articles/PMC7865811/figure/ijms-22-01316-f003/
number: F3
caption: Regulation of NF-κB pathway by NLRX1. 1. In inactivated cells, NLRX1 interacts
  with TRAF6 and inhibits the NF-κB pathway. 2. In activated cells, NLRX1 dissociates
  from TRAF6 via polyubiquitination and binds to IKK complex to prevent NF-κB-mediated
  pro-inflammatory cytokine production. 3. Upon acute injury, activated MAVS, TBK1,
  IKK, IκB, and TRAF6 are recruited to the mitochondrion, where they interact with
  NLRX1, which blocks NF-κB activity.
papertitle: Focusing on the Cell Type Specific Regulatory Actions of NLRX1.
reftext: Tünde Fekete, et al. Int J Mol Sci. 2021 Feb;22(3):1316.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.946099
figid_alias: PMC7865811__F3
figtype: Figure
redirect_from: /figures/PMC7865811__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7865811__ijms-22-01316-g003.html
  '@type': Dataset
  description: Regulation of NF-κB pathway by NLRX1. 1. In inactivated cells, NLRX1
    interacts with TRAF6 and inhibits the NF-κB pathway. 2. In activated cells, NLRX1
    dissociates from TRAF6 via polyubiquitination and binds to IKK complex to prevent
    NF-κB-mediated pro-inflammatory cytokine production. 3. Upon acute injury, activated
    MAVS, TBK1, IKK, IκB, and TRAF6 are recruited to the mitochondrion, where they
    interact with NLRX1, which blocks NF-κB activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nfkb1
  - Myd88
  - Mavs
  - Traf6
  - Nlrx1
  - Nfkbib
  - Chuk
  - Ikbkb
  - NFKB1
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - MYD88
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - MAVS
  - TRAF6
  - NLRX1
  - myd88
  - mavs
  - traf6
  - nlrx1
---
